Overview

Drug Discrimination in Methadone-Maintained Humans Study 2

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study involves giving psychoactive drugs intramuscularly (injected into the muscle of the upper arm or the hip) and/or orally, and measuring the subject's ability to tell the difference between one drug and another, as well as measuring the effects of the drugs on mood, physiology (e.g., heart rate, blood pressure, respiration rate) and behavior. Each subject will receive 2-4 of the listed interventions.
Phase:
Phase 1
Details
Lead Sponsor:
University of Arkansas
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cycloserine
Diltiazem
Gabapentin
Isradipine
Methadone
Naloxone
Nifedipine
Verapamil